Rajendra K Khankari, based in Maple Grove, MN, is a prolific inventor with a remarkable portfolio of 19 patents. His innovative contributions primarily focus on pharmaceutical dosage forms designed to enhance drug absorption through innovative delivery mechanisms.

Latest Patents

Among his most recent advancements are the patents for "Sublingual Buccal Effervescent" and "Transmucosal Effervescent" dosage forms. Both inventions aim to provide an efficient method for delivering medications to the oral cavity, facilitating buccal, sublingual, or gingival absorption. These unique pharmaceutical forms combine oral medications with effervescent agents, promoting enhanced absorption. Additionally, the inclusion of a pH adjusting substance plays a crucial role in further improving drug absorption, offering significant advantages in pharmaceutical applications.

Career Highlights

Rajendra K Khankari has made significant contributions to the field of pharmaceuticals through his roles at notable companies such as Cima Labs Inc. and Cephalon, Inc. His expertise and dedication to innovation have positioned him as a key figure in the development of advanced drug delivery systems.

Collaborations

Throughout his career, Khankari has collaborated with several industry experts, including coworkers John Hontz and Jonathan D Eichman. Their combined efforts in research and development have led to the successful execution of innovative projects that continue to shape the pharmaceutical landscape.

Conclusion

In summary, Rajendra K Khankari stands out as an influential inventor in the pharmaceutical industry. His latest patents reflect a commitment to enhancing drug delivery methods, potentially transforming how medications are administered and absorbed. As the field of pharmaceuticals continues to evolve, Khankari's innovative approach positions him as a leader in the pursuit of effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.